Genasys Inc. (filing identifies registrant as LRAD Corporation) — Form 10-Q summary
Reporting period: Fiscal first quarter ended December 31, 2012; comparisons are with the three months ended December 31, 2011 unless otherwise noted. The filing names LRAD Corporation, while the request metadata names Genasys Inc.; verify the issuer identity or historical-name relationship before relying on this summary.
Business context and financial results
LRAD designed, developed and commercialized directed-sound products for government, military, security, emergency-notification and commercial markets. It cited its LRAD-X product line and newer LRAD 360X and 2000X products as areas of market opportunity.
| Metric | Quarter ended Dec. 31, 2012 | Prior-year quarter | Change / context |
|---|---|---|---|
| Total revenue | $2.980 million | $3.612 million | Down 17.5%; lower U.S. military orders were the primary reason. |
| Product sales | $2.762 million | $3.545 million | Down 22.1%. |
| Contract and other revenue | $218,000 | $67,000 | Included $197,031 from an annual maintenance agreement not in place in the prior-year quarter. |
| Gross profit / margin | $1.486 million / 49.9% | $1.749 million / 48.4% | Profit fell 15.0%; margin improved 1.5 percentage points, reflecting product mix and lower relative cost of revenue. |
| Operating expenses | $1.594 million | $1.438 million | Up 10.9%; SG&A rose 11.0% and R&D rose 10.6%. |
| Operating income (loss) | $(109,000) | $311,000 | Changed from profit to loss. |
| Net income (loss) | $(100,000) | $314,000 | Basic and diluted EPS reported as $0.00 versus $0.01. |
| Operating cash flow | $2.338 million provided | $22,000 used | Primarily benefited from a $3.249 million reduction in receivables; inventory growth used $1.050 million. |
| Cash and cash equivalents | $16.139 million at Dec. 31, 2012 | $13.860 million at Sept. 30, 2012 | Quarterly increase of $2.280 million. |
Liquidity, debt and balance sheet
Current assets were $22.957 million and current liabilities were $1.514 million at December 31, 2012; reported working capital was $21.443 million. Total liabilities were $1.879 million, including $365,000 of noncurrent liabilities. The company reported no debt and said cash, together with expected operating cash flows, should fund operations for the next 12 months under its current plans and operating assumptions. Capital expenditures and patent costs used $78,000 in the quarter. Cash balances in excess of FDIC-insured limits were approximately $13.4 million.
Material changes, outlook and risks
- Management attributed lower revenue mainly to reduced U.S. military orders, amid uncertainty over defense budgets and anticipated spending cuts or sequestration. It expected that uncertainty to continue through at least March 2013.
- Management expected quarterly revenue to remain uneven because of customer budget cycles, limited established markets and unpredictable timing of large opportunities. It gave no numerical revenue or earnings guidance.
- Management cited positive product response and opportunities in international government and military markets and commercial applications, while noting geopolitical and economic uncertainty and the difficulty of forecasting whether or when large prospects would convert to sales.
- Gross margin is exposed to product and sales-channel mix, product updates, component costs and warranty estimates; management cautioned that historical margins may not indicate future margins.
- SG&A increased partly because of $71,432 more noncash share-based compensation and $49,020 more legal fees. Management expected legal costs to rise at least through the second fiscal quarter. R&D increased with product development and customer-project travel; management expected R&D spending for fiscal 2013 to be comparable to the prior year.
- Liquidity risks identified include sales projections, government spending, competition, product mix and margins, inventory reduction and acceptance in new markets. Management cautioned that additional capital could be needed if conditions change and might not be available on acceptable terms.
- Two customers represented 28% and 13% of quarterly revenue. Three customers represented 26%, 25% and 14% of period-end receivables, respectively.
- A shareholder derivative suit alleges fiduciary-duty and other claims concerning stock options issued to directors and officers. The defendants moved to dismiss the amended complaint; the motion was being briefed. The plaintiff also gave notice of its intention to nominate five directors for the 2013 annual meeting. The filing reports no quantified loss estimate for the litigation.
- The company recorded no income tax expense for the quarter and maintained a full valuation allowance against deferred tax assets, citing uncertainty about realization. It also disclosed no recorded expense or benefit for uncertain tax positions.
Most important facts for investors to verify
- Confirm that LRAD Corporation is the intended issuer for this Genasys Inc. request and establish the applicable company/name history.
- Track U.S. defense procurement and whether large international or commercial opportunities convert into orders and recognized revenue.
- Assess the durability of the quarter’s improved gross margin given lower sales, product mix, warranty costs and maintenance obligations.
- Review operating cash generation in light of its reliance on collections of receivables, the increase in inventory and customer concentration.
- Monitor the derivative litigation, director-nomination process and related legal expenses.
- Consider the potential effects of outstanding options and warrants: the filing reported 3.353 million options and 1.628 million warrants outstanding at quarter-end.